A multicenter, multinational analysis of mitomycin C in refractory metastatic colorectal cancer (2012)
- Authors:
- Autor USP: HOFF, PAULO MARCELO GEHM - FM
- Unidade: FM
- DOI: 10.1016/j.ejca.2012.01.008
- Subjects: NEOPLASIAS COLORRETAIS; METÁSTASE NEOPLÁSICA; ADENOCARCINOMA; ANTICORPOS MONOCLONAIS
- Language: Inglês
- Imprenta:
- Source:
- Título: European Journal of Cancer
- ISSN: 0959-8049
- Volume/Número/Paginação/Ano: v. 48, n. 6, p. 820-826, 2012
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- Versão do Documento: Versão submetida (Pré-print)
-
Status: Artigo possui versão em acesso aberto em repositório (Green Open Access) -
ABNT
FERRAROTTO, Renata et al. A multicenter, multinational analysis of mitomycin C in refractory metastatic colorectal cancer. European Journal of Cancer, v. 48, n. 6, p. 820-826, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.ejca.2012.01.008. Acesso em: 11 mar. 2026. -
APA
Ferrarotto, R., Machado, K., Mak, M. P., Shah, N., Takahashi, T. K., Costa, F. P., et al. (2012). A multicenter, multinational analysis of mitomycin C in refractory metastatic colorectal cancer. European Journal of Cancer, 48( 6), 820-826. doi:10.1016/j.ejca.2012.01.008 -
NLM
Ferrarotto R, Machado K, Mak MP, Shah N, Takahashi TK, Costa FP, Overman MJ, Kopetz S, Hoff PM. A multicenter, multinational analysis of mitomycin C in refractory metastatic colorectal cancer [Internet]. European Journal of Cancer. 2012 ; 48( 6): 820-826.[citado 2026 mar. 11 ] Available from: https://doi.org/10.1016/j.ejca.2012.01.008 -
Vancouver
Ferrarotto R, Machado K, Mak MP, Shah N, Takahashi TK, Costa FP, Overman MJ, Kopetz S, Hoff PM. A multicenter, multinational analysis of mitomycin C in refractory metastatic colorectal cancer [Internet]. European Journal of Cancer. 2012 ; 48( 6): 820-826.[citado 2026 mar. 11 ] Available from: https://doi.org/10.1016/j.ejca.2012.01.008 - Should patients with advanced colorectal cancer and ECOG 3/4 be treated with chemotherapy?
- Primary prevention of colorectal cancer: Myth or reality?
- Drogas moleculares
- Perspectivas no cuidado dos tumores gastrointestinais
- Obesidade e câncer
- Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors
- Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer
- Evidence-based recommendations for gastrointestinal cancers during the COVID-19 pandemic by the Brazilian Gastrointestinal Tumours Group
- Lack of association between ERCC1 expression in biliary tract malignancy and response to chemotherapy
- Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
